Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis
BL Pearlman - Digestive Diseases and Sciences, 2024 - Springer
Patients with chronic hepatitis C virus (HCV) infection and decompensated cirrhosis are an
important population for antiviral therapy yet under-represented in clinical trials. HCV direct …
important population for antiviral therapy yet under-represented in clinical trials. HCV direct …
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
BL Pearlman - Digestive Diseases and Sciences, 2024 - europepmc.org
Patients with chronic hepatitis C virus (HCV) infection and decompensated cirrhosis are an
important population for antiviral therapy yet under-represented in clinical trials. HCV direct …
important population for antiviral therapy yet under-represented in clinical trials. HCV direct …
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis
BL Pearlman - Digestive diseases and sciences - pubmed.ncbi.nlm.nih.gov
Patients with chronic hepatitis C virus (HCV) infection and decompensated cirrhosis are an
important population for antiviral therapy yet under-represented in clinical trials. HCV direct …
important population for antiviral therapy yet under-represented in clinical trials. HCV direct …